Locations
Tel Aviv-Yafo, Israel
industry
Biotechnology · DeepTech · Health
Size
51-200 employees
Stage
Other
founded in
2016
CytoReason is re-defining the context of the immune system at a cellular level in order to better understand disease and support more effective drug discovery and development. CytoReason has developed the world’s only machine learning model aimed at re-defining understanding of the immune system and the cells that make it tick. Computationally simulating the cellular environment to stimulate discovery. Our cell-focused approach has been specifically designed to understand how cells are behaving within a disease, tissue or treatment context – and what the impact of that behaviour is - identifying “cause and effect” of the gene/cell/cytokine relationships that lie at the heart of treating disease. Faster and more accurately than ever before.
Something looks off?